SHENZHEN

TerraMaster Launches TRAID+ in the Latest TOS 6 Offering Higher Level of Data Protection for NAS Users

Retrieved on: 
Tuesday, April 9, 2024
NAS, RAID 6, RAID, Migration, Control panel, Computer data storage

While traditional TRAID ensures failure redundancy for one hard drive, TRAID+ doubles this safeguard to cover two drives, significantly bolstering data security.

Key Points: 
  • While traditional TRAID ensures failure redundancy for one hard drive, TRAID+ doubles this safeguard to cover two drives, significantly bolstering data security.
  • This enhancement positions TRAID+ as the premier choice for users prioritizing data integrity.
  • As such, TRAID+ caters more to professional or commercial users with stringent data security needs and the financial means to support it.
  • The industry-leading 4bay NAS F4-424 Pro supports TRAID+ elevating disk array management tool and the latest TOS 6 operating system, providing higher-level data security protection.

OnePlus AI Is Coming: Opening a New Era of AI-Driven, User-Centric Innovation

Retrieved on: 
Wednesday, April 3, 2024
OnePlus Nord, Environment, Intelligence, Pedestrian, AI, OnePlus, LLM, Love, Creativity, Data, Medical device

Arriving on OnePlus devices from April, the new AI Eraser is set to redefine the mobile image editing experience

Key Points: 
  • Shenzhen, China--(Newsfile Corp. - April 3, 2024) - Global technology brand OnePlus today launched its new AI Eraser image editing feature for OnePlus smartphones.
  • Powered by OnePlus' proprietary large language model, AI Eraser marks a revolutionary step forward in smartphone technology, liberating user productivity and creativity with more intuitive experiences.
  • "We believe that the potential for generative AI on mobile devices is enormous, with the power to completely transform productivity and creativity.
  • Starting from April, the feature will be rolled out gradually to OnePlus devices including the OnePlus 12, OnePlus 12R, OnePlus 11, OnePlus Open, and OnePlus Nord CE 4.

Inheritance, Dreams, Future - The Successful Holding of the 2nd HUAPOP Creative Festival in Shenzhen in 2024

Retrieved on: 
Sunday, March 31, 2024
Belt, Southern University, LTD, HUA, Associate, Rejuvenation, Dream, Civilization, Party, Federation, Dafen, Tourism

Shenzhen, China--(Newsfile Corp. - March 31, 2024) - The 2nd HUAPOP Creative Festival with the theme of "Inheritance, Dreams, Future" was held in the forefront city of Shenzhen, a hub of reform, openness, and fashion, on March 26, 2024.

Key Points: 
  • Shenzhen, China--(Newsfile Corp. - March 31, 2024) - The 2nd HUAPOP Creative Festival with the theme of "Inheritance, Dreams, Future" was held in the forefront city of Shenzhen, a hub of reform, openness, and fashion, on March 26, 2024.
  • The festival, organized by the HUAPOP Creative Festival Organizing Committee, aims to promote and showcase the creative achievements of the "HUA" culture from 2022-2023, and to promote and lead the new trend of global "HUAPOP."
  • The 2nd HUAPOP Creative Festival, jointly organized by the HUAPOP Creative Festival Organizing Committee, HUAPOP Industrial Economic Research Institute, National Base For International Cultural Trade (Shenzhen), and 36Kr, has been planned and prepared for nearly 10 months.
  • The 2nd HUAPOP Creative Festival continues the format of "rankings" and selects the HUAPOP Creative Ranking, HUAPOP Popularity Ranking, HUAPOP Institutional Ranking, and HUAPOP City Index.

Huize Holding Limited Announces Participation in the LD Micro Invitational XIV

Retrieved on: 
Tuesday, March 26, 2024
Sofitel New York Hotel

Shenzhen, China--(Newsfile Corp. - March 26, 2024) - Huize Holding Limited (NASDAQ: HUIZ) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024.

Key Points: 
  • Shenzhen, China--(Newsfile Corp. - March 26, 2024) - Huize Holding Limited (NASDAQ: HUIZ) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024.
  • The event is expected to feature 80 companies presenting in half-hour increments, as well as private 1:1 meetings.
  • Huize Holding Limited is scheduled to present on April 9th at 10:00 AM ET.
  • Mr. Ron Tam, Co-Chief Financial Officer, will be leading the presentation.

BAK Battery Unveils Revolutionary Big Cylindrical Power Batteries at China EV100 Forum 2024, Pioneering the Future of Electric Vehicles

Retrieved on: 
Thursday, March 21, 2024
BAK, Temperature, Speech, Senkaku Islands, Diaoyutai State Guesthouse, Kilowatt-hour, Electric battery

At the China EV100 Forum 2024, Dr. Lin from BAK Battery highlighted the potential of big cylindrical power batteries as the future of EVs, suggesting ultra-fast charging and enhanced safety features.

Key Points: 
  • At the forum, Dr. Lin Jian from Shenzhen BAK Power Battery Co., Ltd. (hereinafter referred to as "BAK Battery") delivered a keynote speech to analyze the global power battery market.
  • According to Dr. Lin, with the global battery supply and demand imbalance, big cylindrical power batteries will emerge as the new engine of electric vehicles.
  • Dr. Lin went on to discuss the applicability of big cylindrical batters in mid- to high-end electric vehicles when compared with prismatic and polymer batteries.
  • Big cylindrical batteries are expected to promote the iterative upgrade of power battery technologies and emerge as the new engine of electric vehicles.

Introducing Hornbill M1 Keyless Entry Door Lock - A Seamless Blend of Security and Convenience

Retrieved on: 
Thursday, March 21, 2024
Element, IC, IP65, M1, Longevity, Hornbill

Shenzhen, China--(Newsfile Corp. - March 21, 2024) - Hornbill proudly presents its latest innovation, the M1 Keyless Entry Door Lock , a stylish enhancement to any home security system.

Key Points: 
  • Shenzhen, China--(Newsfile Corp. - March 21, 2024) - Hornbill proudly presents its latest innovation, the M1 Keyless Entry Door Lock , a stylish enhancement to any home security system.
  • To view an enhanced version of this graphic, please visit:
    The M1 transcends traditional keyless entry systems, boasting a versatile array of features tailored to enhance security and convenience.
  • Offering multiple unlocking options, from Bluetooth app control to IC card unlock, and a discrete anti-peep passcode feature, the M1 ensures secure access without compromising convenience.
  • Its user-friendly design facilitates easy installation on US standard doors, backed by comprehensive instructions and installation videos for hassle-free setup.

CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia

Retrieved on: 
Monday, April 1, 2024
Dermatology, Vitiligo, Prurigo nodularis, Patient, Collaboration, Research, Asthma, JAK1, HS, Hidradenitis suppurativa, PN, CMS, Autoimmunity, Pharmaceutical industry

Under the terms of the agreement, CMS will make an upfront payment to Incyte and Incyte is eligible to receive additional potential development and commercial milestones and royalties on net sales of the licensed product in CMS’ territory.

Key Points: 
  • Under the terms of the agreement, CMS will make an upfront payment to Incyte and Incyte is eligible to receive additional potential development and commercial milestones and royalties on net sales of the licensed product in CMS’ territory.
  • CMS will receive an exclusive license to develop and commercialize and a non-exclusive license to manufacture povorcitinib in autoimmune and inflammatory dermatologic diseases, including non-segmental vitiligo, hidradenitis suppurativa (HS), prurigo nodularis (PN), asthma and chronic spontaneous urticaria, for patients in mainland China, Hong Kong, Macau, Taiwan and certain countries in Southeast Asia.
  • “We are excited to announce the addition of this collaboration for povorcitinib, expanding our relationship with CMS in the Dermatology space beyond ruxolitinib cream, to include two products with the potential to help patients with limited treatment options,” said Herve Hoppenot, Chief Executive Officer, Incyte.
  • Upon approval, povorcitinib is poised to synergize with the innovative drugs in the commercialization stage of our pipeline ILUMETRI (tildrakizumab injection), original drugs including Hirudoid (mucopolysaccharide polysulfate cream) and Aethoxysklerol (polidocanol injection) in terms of our network and market resources, which will help the Product to realize its clinical and commercial value.”
    The transaction is effective immediately upon the execution of the Collaboration and License Agreement.

XPPen Partners with HoYoFair to Launch Genshin Impact Profession Inspiration Fan Art Contest, Exploring the Anime Aesthetics of Gaming World

Retrieved on: 
Sunday, March 31, 2024
Genshin Impact, Partnership, Pixiv, MiHoYo, Imagination, Exhibition, Creativity, Dream, Magic, Creative industries

Shenzhen, China, March 31, 2024 (GLOBE NEWSWIRE) -- XPPen proudly announces the partnership with HoYoFair2024 Genshin Impact Profession Inspiration Fan Art Contest, launching the #TeyvatFashion character costume design event.

Key Points: 
  • Shenzhen, China, March 31, 2024 (GLOBE NEWSWIRE) -- XPPen proudly announces the partnership with HoYoFair2024 Genshin Impact Profession Inspiration Fan Art Contest, launching the #TeyvatFashion character costume design event.
  • XPPen Joined Hands with HoYoFair, Launch #TeyvatFashion Creative Contest
    HoYoFair provides a platform for global players and creators to engage and share their artistic endeavors.
  • HoYoFair 2024 Genshin Impact Profession Inspiration Fan Art Contest draws inspiration from character costumes, and invites participants to unleash boundless imagination and sketch out brand-new character legends.
  • XPPen joined hands with HoYoFair to launch the HoYoFair 2024 Genshin Impact Profession Inspiration Fan Art Contest, embodying the shared pursuit in the digital art realm.

China Medical System （867.HK）2023 Annual Results: Despite of the Temporary Financial Performance Pressure Fresh Catalysts Emerged from Successive Innovation Breakthroughs

Retrieved on: 
Thursday, March 28, 2024
Sclerotherapy, RMB, Conditional sentence, NDA, IND, Creativity, Small RNA, Marketing, Gastroenterology, Central nervous system, FIC, City, BIC, CMS, NRDL, Injection, Dermatology, CDMO, Commercialization, Tablet, Pharmacy, Methotrexate, Hospital, Acquisition, Gonadotropin-releasing hormone, RCT, VBP, Rheumatoid arthritis, Growth, Varicose veins, Ecosystem, Blue, Government, Ophthalmology

SHENZHEN, CHINA, March 27, 2024 (GLOBE NEWSWIRE) -- On March 27, 2024, China Medical System (“CMS” or the “Company”) released its 2023 annual results.

Key Points: 
  • SHENZHEN, CHINA, March 27, 2024 (GLOBE NEWSWIRE) -- On March 27, 2024, China Medical System (“CMS” or the “Company”) released its 2023 annual results.
  • Based on above, CMS has successfully entered into its “New Period” of innovation and internationalization development.
  • 4 innovative drugs have started large-scale clinical application, unveiling CMS’s first year of commercialization era of innovative drugs.
  • Under its compliant and efficient commercialization system, the Company's innovative products and exclusive drugs will grow steadily.

Linklogis Announces 2023 Annual Results: Maintaining the Largest Market Share in China for 4 Consecutive Years

Retrieved on: 
Tuesday, March 26, 2024
Cloud, Transfer, Vietnamese, PDD, OPPO, Contribution, Standard Chartered, GPT, Intellectual property, Bank, Sustainalytics, Social responsibility, Multi, Risk assessment, Supply chain, SME, Share repurchase, Digital, Intelligence, ESG, TBI, Acquisition, AI, Ecology, ChatGPT, Development, Growth, Blockchain, KYC, Cross, CMMI, Infor, LDP, Cryptocurrency

Beijing, China, March 26, 2024 (GLOBE NEWSWIRE) -- On March 26, 2024, Linklogis Inc. (09959.HK, “Linklogis”), a leading supply chain finance technology solution provider in China, released its 2023 annual results.

Key Points: 
  • Beijing, China, March 26, 2024 (GLOBE NEWSWIRE) -- On March 26, 2024, Linklogis Inc. (09959.HK, “Linklogis”), a leading supply chain finance technology solution provider in China, released its 2023 annual results.
  • The board of directors of Linklogis proposes to pay a special dividend of HK$0.1 per share, totaling approximately HK$230 million.
  • Furthermore, the board expresses confidence in the company’s prospects and sustained growth in the future, and announces a share repurchase plan of up to US$100 million.
  • According to China Insights Consultancy, Linklogis held 20.9% market share, ranking No.1 in the third-party supply chain finance technology solutions providers in China for the fourth consecutive year.